Cargando…
Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
Liver stereotactic body radiotherapy (SBRT) is a local treatment that provides good local control and low toxicity. We present the first clinical results from our prospective registry of stereotactic MR-guided radiotherapy (MRgRT) for liver metastases. All patients treated for liver metastases were...
Autores principales: | Bordeau, Karl, Michalet, Morgan, Keskes, Aïcha, Valdenaire, Simon, Debuire, Pierre, Cantaloube, Marie, Cabaillé, Morgane, Jacot, William, Draghici, Roxana, Demontoy, Sylvain, Quantin, Xavier, Ychou, Marc, Assenat, Eric, Mazard, Thibault, Gauthier, Ludovic, Dupuy, Marie, Guiu, Boris, Bourgier, Céline, Aillères, Norbert, Fenoglietto, Pascal, Azria, David, Riou, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917771/ https://www.ncbi.nlm.nih.gov/pubmed/36769831 http://dx.doi.org/10.3390/jcm12031183 |
Ejemplares similares
-
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study
por: Bordeau, Karl, et al.
Publicado: (2022) -
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study
por: Michalet, Morgan, et al.
Publicado: (2022) -
Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
por: Michalet, Morgan, et al.
Publicado: (2022) -
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma
por: Cantaloube, Marie, et al.
Publicado: (2021) -
Magnetic Resonance–Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry Study
por: Michalet, Morgan, et al.
Publicado: (2021)